Skip to results
Modify your search
NARROW
1-9 of 9
Authors: Lisa G Spencer
Sort by
Journal Article
Management and outcomes of interstitial lung disease associated with anti-synthetase syndrome: a systematic literature review
Get access
Koushan Kouranloo and others
in
Rheumatology
Rheumatology, Volume 64, Issue 1, January 2025, Pages 45–55, https://doi.org/10.1093/rheumatology/keae403
Published: 31 July 2024
Journal Article
E064 Identifying patients with pulmonary disease in a mixed connective tissue disease cohort
Rosalind Benson and others
in
Rheumatology
Rheumatology, Volume 63, Issue Supplement_1, April 2024, keae163.291, https://doi.org/10.1093/rheumatology/keae163.291
Published: 24 April 2024
Journal Article
The diagnosis and management of systemic autoimmune rheumatic disease-related interstitial lung disease: British Society for Rheumatology guideline scope
Jennifer Hannah and others
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae056, https://doi.org/10.1093/rap/rkae056
Published: 18 April 2024
Journal Article
OA12 Autoantibodies are common in patients labelled as “idiopathic” interstitial lung disease suggesting a high prevalence of undiagnosed autoimmune connective tissue disease
Sarah L Tansley and others
in
Rheumatology
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.011, https://doi.org/10.1093/rheumatology/keac132.011
Published: 23 April 2022
Journal Article
P221 Autoantibodies are common in patients with idiopathic interstitial lung disease, suggesting a high prevalence of undiagnosed autoimmune connective tissue disease
Sarah Tansley and others
in
Rheumatology
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.220, https://doi.org/10.1093/rheumatology/keac133.220
Published: 23 April 2022
Journal Article
O24 Low level detection of CTD-associated autoantibodies in patients with idiopathic pulmonary fibrosis confirms this as a robust phenotype when diagnosed on clinical grounds alone
Get access
Caroline V Cotton and others
in
Rheumatology
Rheumatology, Volume 57, Issue suppl_3, April 2018, key075.206, https://doi.org/10.1093/rheumatology/key075.206
Published: 25 April 2018
Journal Article
MUSCLE DISORDERS275. COMPREHENSIVE CONNECTIVE TISSUE DISEASE SEROLOGY COULD PREVENT UNNECESSARY LUNG BIOPSIES IN AMYOPATHIC INTERSTITIAL LUNG DISEASE PATIENTS WITH ANTI-SYNTHETASES OTHER THAN ANTI-JO-1: AN ILLUSTRATIVE CASE SERIES
Get access
Caroline V. Cotton and others
in
Rheumatology
Rheumatology, Volume 56, Issue suppl_2, April 2017, kex062.277, https://doi.org/10.1093/rheumatology/kex062.277
Published: 21 April 2017
Journal Article
The utility of comprehensive autoantibody testing to differentiate connective tissue disease associated and idiopathic interstitial lung disease subgroup cases
Caroline V. Cotton and others
in
Rheumatology
Rheumatology, Volume 56, Issue 8, August 2017, Pages 1264–1271, https://doi.org/10.1093/rheumatology/kew320
Published: 20 October 2016
Journal Article
176 When Interstitial Lung Disease Represents the Major Clinical Feature in Antisynthetase Syndrome Cases which are Clearly Amyopathic, is it Justifiable to Still Regard Detected Antisynthetases as Myositis-Specific Antibodies?
Get access
Caroline V. Cotton and others
in
Rheumatology
Rheumatology, Volume 55, Issue suppl_1, April 2016, Page i133, https://doi.org/10.1093/rheumatology/kew135.003
Published: 24 April 2016
Advertisement
Advertisement